title: Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin.
authors.forename: Rafael
authors.initials: R
authors.lastname: Bárcena
authors.forename: Luis
authors.initials: L
authors.lastname: Gil-Grande
authors.forename: Javier
authors.initials: J
authors.lastname: Moreno
authors.forename: José R
authors.initials: JR
authors.lastname: Foruny
authors.forename: Elena
authors.initials: E
authors.lastname: Otón
authors.forename: Miguel
authors.initials: M
authors.lastname: García
authors.forename: Javier
authors.initials: J
authors.lastname: Blázquez
authors.forename: Juan
authors.initials: J
authors.lastname: Sánchez
authors.forename: Ana
authors.initials: A
authors.lastname: Moreno
authors.forename: Alberto
authors.initials: A
authors.lastname: Moreno
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic / Q000379:methods*; D006526:Hepatitis C / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D013154:Spleen / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b